BNP Paribas Financial Markets
AMPE

BNP Paribas Financial Markets’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

BNP Paribas Financial Markets’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-76
Closed -$1.39K – 5003
2022
Q3 		$1.39K Sell
76
-40
-34% -$1.4K ﹤0.01% 4387
2022
Q2 		$5.86K Buy
116
+59
+104% +$4.39K ﹤0.01% 3805
2022
Q1 		$8.1K Sell
57
-81
-59% -$11.8K ﹤0.01% 3829
2021
Q4 		$23.7K Buy
138
+22
+19% +$8.2K ﹤0.01% 3838
2021
Q3 		$58K Buy
116
+92
+383% +$42.7K ﹤0.01% 3480
2021
Q2 		$12.2K Buy
+24
New +$12.9K ﹤0.01% 3674
2020
Q3 		– Sell
-1
Closed -$104 – 4321
2020
Q2 		$104 Sell
1
-1
-50% -$166 ﹤0.01% 4218
2020
Q1 		$285 Hold
2
– – ﹤0.01% 4165
2019
Q4 		$400 Sell
2
-39
-95% -$5.04K ﹤0.01% 4268
2019
Q3 		$6.13K Hold
41
– – ﹤0.01% 4243
2019
Q2 		$4.74K Sell
41
-45
-52% -$7.13K ﹤0.01% 4251
2019
Q1 		$14.6K Buy
86
+80
+1,333% +$13.7K ﹤0.01% 3969
2018
Q4 		$740 Sell
6
-3
-33% -$460 ﹤0.01% 3961
2018
Q3 		$1.32K Hold
9
– – ﹤0.01% 4298
2018
Q2 		$5.76K Buy
+9
New +$6.73K ﹤0.01% 4037
2018
Q1 		– Hold
0
– – – 4152
2017
Q4 		– Hold
0
– – – 4139
2017
Q3 		– Hold
0
– – – 4203
2017
Q2 		– Sell
-2
Closed -$404 – 4227
2017
Q1 		$540 Sell
2
-2
-50% -$538 ﹤0.01% 3836
2016
Q4 		$1.05K Sell
4
-9
-69% -$2.14K ﹤0.01% 4016
2016
Q3 		$2.87K Buy
13
+7
+117% +$1.96K ﹤0.01% 3443
2016
Q2 		$2.24K Buy
+6
New +$6.55K ﹤0.01% 3441
2015
Q2 		– Sell
-3
Closed -$7.27K – 3658
2015
Q1 		$7.27K Buy
+3
New +$5.12K ﹤0.01% 2936
2014
Q4 		– Sell
-8
Closed -$8.83K – 3429
2014
Q3 		$8.83K Buy
8
+7
+700% +$11.8K ﹤0.01% 3648
2014
Q2 		$3.1K Sell
1
-2
-67% -$4.08K ﹤0.01% 2851
2014
Q1 		$6.29K Sell
3
-1
-25% -$2.37K ﹤0.01% 2372
2013
Q4 		$9.46K Buy
+4
New +$9.46K ﹤0.01% 2679
2013
Q3 		– Sell
-39
Closed -$67.6K – 2761
2013
Q2 		$67.6K Buy
+39
New +$61.9K ﹤0.01% 2616

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $4.53B AUM 21.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

BNP Paribas Financial Markets's AMPE Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 76 shares — an estimated $1.39K sold.

BNP Paribas Financial Markets first reported a position in AMPE in Q2 2013 and held it in 25 quarters. The position peaked at $67.6K in Q2 2013. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 76 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1.39K.
  • BNP Paribas Financial Markets first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 25 quarters.
  • BNP Paribas Financial Markets's Ampio Pharmaceuticals Inc. position peaked at $67.6K in Q2 2013.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.